Filter
818
Text search:
drug
prices
Featured
Recommendations
74
New Publications
247
Language
Document type
No document type
485
Studies & Reports
171
Guidelines
78
Strategic & Response Plan
36
Manuals
21
Situation Updates
8
Fact sheets
8
Training Material
4
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
Global
36
India
30
Kenya
28
Uganda
21
Myanmar / Burma
20
Western and Central Europe
17
Liberia
15
Nepal
15
Malawi
15
Zambia
14
South Africa
14
Ukraine
12
Sierra Leone
11
Nigeria
11
Ghana
11
Tanzania
11
Bangladesh
11
Latin America and the Carribbean
11
Zimbabwe
9
Africa
9
Ethiopia
8
Philippines
8
Syria
8
Indonesia
8
Namibia
8
Congo, Democratic Republic of
7
Botswana
7
South–East Asia Region
7
Cameroon
6
Mozambique
6
Asia
6
Eastern Europe
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Venezuela
3
Tajikistan
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Switzerland
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
316
Clinical Guidelines
80
Public Health
44
Pharmacy & Technologies
20
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
108
Mental Health
79
Pharmacy
56
TB
47
AMR
47
COVID-19
31
NCDs
19
Global Health Education
17
Health Financing Toolbox
17
Conflict
12
NTDs
11
Planetary Health
9
Malaria
9
Ebola & Marburg
8
Refugee
8
Disability
7
Caregiver
6
Polio
4
Natural Hazards
3
Rapid Response
3
Cholera
2
2.0 Rapid Response
1
Accessed: 22.03.2019
A summary of the national drug situation
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significa
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
In 2019, the Task Force on Fiscal Policy for Health concluded that taxes on tobacco, alcohol, and sugar-sweetened beverages were a highly effective but greatly underused policy tool to reduce consumption, save lives, and raise domestic resources. The Task Force estimated that if all countries increa
...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T
...
